|
Mood Stabilizers
LITHIUM:
For "rapid cyclers" or for those that cannot tolerate lithium, Tegretol and Depakote are usually effective alternatives.
DEPAKOTE:
TEGRETOL:
NEURONTIN, LAMICTAL, TOPAMAX, GABITRIL, and TRILEPTAL: Neurontin seems to have very few side effects, does not cause weight gain, and can be used safely with other medications needed by a patient with bipolar disorder.
Lamictal seems to have many advantages over other antimanic medications: It is frequently effective for controlling "rapid cycling" and mixed states, it seems to work in the depressed phase of bipolar disorder, and it does not appear to cause weight gain. Most people tolerate the drug well and experience minimal side effects, but there is one side effect of great concern to those taking Lamictal. Some people taking the drug develop a rash that in some instances is associated with a life-threatening syndrome known as Stevens-Johnson syndrome. This is a severe and sometimes fatal allergic reaction to an infectious disease or a drug. As a result, until further studies are done, the FDA has placed this drug on the black label: It is not to be given to children under the age of sixteen.
Topamax is chemically unrelated to any other anticonvulsant or mood stabilizing medication. Some clinicians believe that a patient on Topamax can take an antidepressant and resist any tendency to switch into hypomania or mania or to suffer increased speed or intensity of cycling, but this has yet to be proven.
Gabitril has not been widely studied yet, and there is little known yet about the its effectiveness, but it is being prescribed more and more in the treatment of bipolar disorder.
Trileptal is becoming more and more popular as a treatment for bipolar disorder. This drug is nearly the same as Tegretol, but reports of side effects are less, and it does not decrease white blood cells like Tegretol does. Once more evidence of its effectiveness is established, this medication may become a first line treatment for mood stabilization.
| |||||
This Site Updated 06/20/08